CD8A and cancer: Coculture of CD8+ OT-I T cells with either Usp22 KO MC38 or RM1 cancer cells with stable OVA expression enhanced CD8+ T cell activation, indicated by elevated CD69 expression and tumor cell killing (Figure 1, E–H).